Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 6/20 | 0.52 |
| ▸ | RARB | P10826 | 6/20 | 0.52 |
| ▸ | RARG | P13631 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.52 |
| ▸ | GOT1 | P17174 | 1/20 | 0.52 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9122371 | 0.89 | RARA (0.54) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9320668 | 0.86 | RARA (0.55) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9122383 | 0.85 | KMT2A (0.51) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9160250 | 0.82 | MEN1 (0.52) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9320581 | 0.82 | RARA (0.53) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9292104 | 0.80 | RARA (0.55) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL30873722 | 0.80 | KMT2A (0.51) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL9125797 | 0.80 | KMT2A (0.51) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL29190709 | 0.80 | KMT2A (0.51) | RARARARBRARGMEN1KMT2A | |
| SCHEMBL20322856 | 0.80 | PPARG (0.40) | RARARARBRARGMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107427431-B | Antioxidant or anti-aging composition comprising 5-adamantan-1-yl-N- (2, 4-dihydroxybenzyl) -2, 4-dimethoxybenzamide | 株式会社爱茉莉太平洋 | 2021-04-13 | — | — | CN | disclosed |
| EP-3278790-B1 | ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE | AMOREPACIFIC CORP (KR) | 2021-03-24 | — | — | EP | disclosed |
| EP-3318550-B1 | METHOD FOR PREPARING A BENZOIC ACID AMIDE COMPOUND | AMOREPACIFIC CORP (KR) | 2020-03-04 | — | — | EP | disclosed |
| US-20180116933-A1 | ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE | AMOREPACIFIC CORPORATION (KR) | 2018-05-03 | — | — | US | disclosed |
| EP-3278790-A2 | ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE | Amorepacific Corporation (KR) | 2018-02-07 | — | — | EP | disclosed |
| EP-2740721-B1 | NOVEL BENZOIC ACID AMIDE COMPOUND | AMOREPACIFIC CORP (KR) | 2017-03-22 | — | — | EP | disclosed |
| US-9433593-B1 | Composition for anti-inflammation containing 5-adamantan-1-yl-N-(2,4-dihydroxy-benzyl)-2,4-dimethoxy-benzamide | AMOREPACIFIC CORPORATION (KR) | 2016-09-06 | — | — | US | disclosed |
| CN-103702977-B | Benzoic acid amide compound | 株式会社爱茉莉太平洋 | 2016-08-17 | — | — | CN | disclosed |
| US-9254251-B2 | Benzoic acid amide compound | AMOREPACIFIC CORPORATION (KR) | 2016-02-09 | — | — | US | disclosed |
| US-20140234241-A1 | NOVEL BENZOIC ACID AMIDE COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2014-08-21 | — | — | US | disclosed |
| EP-2740721-A2 | NOVEL BENZOIC ACID AMIDE COMPOUND | Amorepacific Corporation (KR) | 2014-06-11 | — | — | EP | disclosed |
| CN-103702977-A | Novel benzoic acid amide compound | AMORE PACIFIC CORP | 2014-04-02 | — | — | CN | disclosed |
| EP-0409729-B1 | Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics | CIRD GALDERMA (FR) | 1994-01-12 | — | — | EP | disclosed |
| EP-0409729-A1 | Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234241-A1 | NOVEL BENZOIC ACID AMIDE COMPOUND | TYR, AADAC, CUTA | RARA 148/4885RARB 216/4885RARG 185/4885 |
| US-20180116933-A1 | ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE | MMP14, DNASE1, MMP15 | RARA 2089/4885RARB 1643/4885RARG 2745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.